Performance of the 2017 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria in Patients With Idiopathic Inflammatory Myopathy and Anti –Melanoma Differentiation–Associated Protein 5 Positivity
ConclusionIn this cohort of patients with anti –MDA-5–positive IIM, the diagnosis could not be classified by the EULAR/ACR criteria in almost 30% of patients. We suggest incorporating anti–MDA-5 antibody positivity as a criterion into existing criteria sets or developing specific criteria for patients with anti–MDA-5–positive IIM.
Source: Arthritis and Rheumatology - Category: Rheumatology Authors: Ho So,
Jacqueline So,
Tommy Tsz ‐On Lam,
Victor Tak‐Lung Wong,
Roy Ho,
Wai Ling Li,
Chi Chiu Mok,
Chak Sing Lau,
Lai‐Shan Tam Tags: Brief Report Source Type: research
More News: Arthritis | Dermatology | Dermatomyositis | Electronic Medical Records (EMR) | Hong Kong Health | Melanoma | Rheumatology | Skin Cancer | Study